Neonatal illicit drug screening practices in Iowa: The impact of utilization of a structured screening protocol

Journal of Perinatology

Volumn 26, Issue 11, 2006, Pages 660-666

  Oral, R ^a   Strang, T ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG;

ALCOHOL CONSUMPTION; ARTICLE; CHILD ABUSE; CHILDBIRTH; CIGARETTE SMOKING; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONGENITAL MALFORMATION; CONTROLLED STUDY; DELIVERY; DEPRESSION; DOMESTIC VIOLENCE; DRUG DEPENDENCE TREATMENT; HEAD CIRCUMFERENCE; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEART INFARCTION; HOSPITAL BED CAPACITY; HOSPITAL PATIENT; HUMAN; HYPERTENSION; LABOR COMPLICATION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL BEHAVIOR; MULTIPARA; NEWBORN; NEWBORN SCREENING; OUTPATIENT; PREGNANCY; PREMATURITY; PRENATAL CARE; PRENATAL DRUG EXPOSURE; PREVALENCE; PROSTITUTION; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; SOLUTIO PLACENTAE; STANDARDIZATION; STROKE; UNITED STATES; URBANIZATION; WITHDRAWAL SYNDROME;

CLINICAL PROTOCOLS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HEALTH CARE SURVEYS; HOSPITALS, MATERNITY; HUMANS; INFANT, NEWBORN; IOWA; NEONATAL ABSTINENCE SYNDROME; NEONATAL SCREENING; OBSTETRICS AND GYNECOLOGY DEPARTMENT, HOSPITAL; ORGANIZATIONAL POLICY; PREGNANCY; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 33750469706     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211601     Document Type: Article

References (42)

1. Bar-Oz B, Klein J, Karaskov T, Koren G. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed 2003; 88: 98-100.
2. Hohman MM, Shillington AM, Baxter HG. A comparison of pregnant women presenting for alcohol and other drug treatment by CPS status. Child Abuse Negl 2003; 27(2): 303-318.
3. Ostrea EM, Brady M, Gause S, Raymundo AL, Stevens M. Drug screening of newborns by meconium analysis: A large-scale, prospective, epidemiologic study. Pediatrics 1992; 89(1): 107-113.
4. Eyler FD, Behnke M, Conlon M, Woods NS, Wobie K. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: II. Interactive and dose effects on neurobehavioral assessment. Pediatrics 1998; 101(2): 237-241.
5. Frohna JG, Lantz PM, Pollack H. Maternal substance abuse and infant health: Policy options across the life course. Millbank Q 1999; 77(4): 531-570.
6. Chasnoff IJ. Cocaine, pregnancy, and the growing child. Curr Probl Pediatr Adolesc Health Care 1992; 22(7): 302-321.
7. Griffith DR. Prenatal exposure to cocaine and other drugs: Developmental and educational prognoses. Phi Delta Kappan 1992; 9: 30-34.
8. Albert V, Klein D, Noble A, Zahand E, Holtby S. Identifying substance abusing delivering women: Consequences for child maltreatment reports. Child Abuse Negl 2000; 24(2): 173-183.
9. Zellman GL, Fair CC, Hoube J, Wong M. A search for guidance: Examining prenatal substance exposure protocols. Matern Child Health J 2002; 6(3): 205-212.
10. Arizona State Department of Public Health Practice Improvement Protocol 5. Substance use, abuse and/or dependence in pregnant and postpartum women. http://www.azdhs.gov/bhs/guidance/substance.pdf.
11. Washington State Department of Public Health Guidelines for screening substance abuse during pregnancy. http://www.doh.wa.gov/Publicat/ Screening_Guidelines.pdf.
12. Indiana State Department of Public Health Newborn Meconium Screening Program. http://www.in.gov/isdh/programs/nbs/MecScrCriteria.htm.
13. Iowa Hospital Association. http://www.ihaonline.org/publications/ profileserv/profileserv.shtml.
14. Ostrea EM, Knapp DK, Tannenbaum L, Ostrea AR, Romero A, Salari V et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 2001; 138(3): 344-348.
15. Appel PW, Hoffman JH, Blane HT, Frank B, Oldak R, Burke M. Comparison of self-report and hair analysis in detecting cocaine use in a homeless/ transient sample. J Psychoactive Drugs 2001; 33(1): 47-55.
16. Bibb KW, Stewart DL, Walker JR, Cook VD, Wagener RE. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews. J Perinatol 1995; 15(3): 199-202.
17. Sweeney PJ, Schwartz RM, Mattis NG, Vohr B. The effect of integrating substance abuse treatment with prenatal care on birth outcome. J Perinatol 2000; 4: 219-224.
18. Brown JV, Bakeman R, Coles CD, Platzman KA, Lynch ME. Prenatal cocaine exposure: A comparison of two year-old children in parental and nonparental care. Child Dev 2004; 75(4): 1282-1295.
19. Berger L, Waldfogel J. Prenatal cocaine exposure: Long-rung effects and policy implications. Soc Serv Rev 2000; 74(1): 28-54.
20. El-Mohandes A, Herman AA, Nabil El-Khorazaty M, Katta PS, White D, Grylack L. Prenatal care reduces the impact of illicit drug use on perinatal outcomes. J Perinatol 2003; 23(5): 354-360.
21. Little BB, Snell LM, Van Beveren TT, Crowell RB, Trayler S, Johnston WL. Treatment of substance abuse during pregnancy and infant outcome. Am J Perinatol 2003; 20(5): 255-262.
22. Zellman GL, Bell RM, Archie C, DuPlessis H, Hoube J, Miu A. Physician response to prenatal substance exposure. Matern Child Health J 1999; 3(1): 29-38.
23. Jaudes PK, Ekwo E, Van Voorhis J. Association of drug abuse and child abuse. Child Abuse Negl 1995; 19(9): 1065-1075.
24. Easton S, Oral R. Factors associated with parental drug involvement in confirmed cases of child maltreatment. Proceedings of 19th San Diego Conference on Child maltreatment, San Diego, California, January 24-28 2005.
25. Locke TF, Newcomb M. Child maltreatment, parent alcohol and drug-related problems, polydrug problems, and parenting practices: A test of gender differences and four theoretical perspectives. J Fam Psychol 2004; 18(1): 120-134.
26. Stein JA, Leslie MB, Nyamathi A. Relative contributions of parent substance use and childhood maltreatment to homelessness, depression, and substance abuse problems among homeless women: Mediating roles of self-esteem and abuse in adulthood. Child Abuse Negl 2002; 26(10): 1011-1027.
27. Walsh C, MacMillan HL, Jamieson E. The relationship between parental substance abuse and child maltreatment: Findings from the Ontario Health Supplement. Child Abuse Negl 2003; 27(12): 1409-1425.
28. Nair P, Schuler ME, Black MM, Kettinger L, Harrington D. Cumulative environmental risk in substance abusing women: Early intervention, parenting stress, child abuse potential and child development. Child Abuse Negl 2003; 27(9): 997-1017.
29. Azuma SD, Chasnoff IJ. Outcome of children prenatally exposed to cocaine and other drugs: A path analysis of three-year data. Pediatrics 1993; 92(3): 396-402.
30. Chasnoff IJ, Anson A, Hatcher R, Stenson H, Iaukea K, Randolph LA. Prenatal exposure to cocaine and other drugs: Outcome at four to six years. Ann NY Acad Sci 1998; 846: 314-328.
31. Van Dyke DC, Fox AA. Fetal drug exposure and its possible implications for learning in the preschool and school-age population. J Learn Disabil 1990; 23(3): 160-163.
32. Tyler R, Howard J, Espinosa M, Doakes SS. Placement with substance-abusing mothers vs placement with other relatives: Infant outcomes. Child Abuse Negl 1997; 21(4): 337-349.
33. Oral R, Mueller R, Ahmed W. Prevalence of known risk factors for in-utero illicit drug exposure in mother-infant dyads admitted to UIHC for delivery in 2002-2003. Postgraduate Conference Proceedings, 23-24 September 2005, Iowa City, Iowa.
34. Kwong TC, Ryan RM. Detection of intrauterine illicit drug exposure by newborn testing. Clin Chem 1997; 43(1): 235-242.
35. O'Connor TA, Bondurant HH, Siddiqui J. Targeted perinatal drug screening in a rural population. J Matern Fetal Neonatal Med 1997; 6(2): 108-110.
36. Chasnoff IJ, Landress HJ, Barrett ME. Prevalence of illicit drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med 1990; 322(17): 1202-1206.
37. Birchfield M, Scully J, Handler A. Perinatal screening for illicit drugs: Policies in hospitals in a large metropolitan area. J Perinatol 1995; 15: 208-214.
38. Zellman GL, Jacobson PD, Bell RM. Influencing physician response to prenatal substance exposure through state legislation and work place policies. Addiction 1997; 92(9): 1123-1131.
39. Ondersma SJ, Simpson SM, Brestan EV, Ward M. Prenatal drug exposure and social policy: The search for an appropriate response. Child Maltreat 2000; 5(2): 93-108.
40. Adirim TA, Sen Gupta N. A national survey of state maternal and newborn drug testing and reporting policies. Public Health Rep 1991; 106(3): 292-296.
41. Annas GJ. Testing poor pregnant patients for cocaine - physicians as police investigators. N Engl J Med 2001; 344(22): 1729-1732.
42. Ondersma SJ, Malcoe LH, Simpson SM. Child protective services' response to prenatal drug exposure: Results from a nationwide survey. Child Abuse Negl 2001; 25(5): 657-668.